TIS 0.00% 0.0¢ tissue therapies limited

back of envelope calculations

  1. 1,960 Posts.
    lightbulb Created with Sketch. 93
    After reading the prospectus I took an envelope and jotted down a few figures ( apologies to TDA and others who have done much more thorough calculations )
    "World wide sales estimated at 14 Billion"
    Lets be conservative and cut that in half to 7 Billion.
    Being the most effective treatment available,CHEAP,easy to use
    etc.surely we could capture 20% of the market = 1.7 Billion.
    Lets say we get a royalty of 15% that gives TIS an income of 210 million.
    That is $ 1.25 per share.PE of 8= $10.00 share price.
    Well worth waiting for.




 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.